Anna Wilde Mathews
Health Reporter at The Wall Street Journal
Reporter for the Wall Street Journal covering health insurers and reimbursement policy. Reach me at [email protected]
Articles
-
1 day ago |
wsj.com | Anna Wilde Mathews |Christopher Weaver
Andrew Witty steps down after steep share decline; Chairman Stephen Hemsley returns as CEOUnitedHealth Group said Chairman Stephen Hemsley will return to running the healthcare giant he helped build, succeeding Chief Executive Andrew Witty. Effective immediately, Witty is stepping down for “personal reasons,” the company said. Copyright ©2025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8Subscribe NowAlready a subscriber? Sign In
-
1 week ago |
wsj.com | Anna Wilde Mathews
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed byour Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contactDow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/business/earnings/cvs-health-cvs-q1-earnings-report-2025-3f9621e5
-
3 weeks ago |
wsj.com | Anna Wilde Mathews |Dean Seal
UnitedHealth Group’s UNH -21.42%decrease; red down pointing triangle shares nosedived Thursday morning after earnings fell short of Wall Street’s expectations, and the healthcare company substantially downgraded its projected results for 2025, citing problems in its Medicare business. There were steep declines in share prices across the insurance industry, as investors reacted to the bellwether company’s unexpected financial woes. Shares of UnitedHealth fell about 20% in early trading.
-
1 month ago |
wsj.com | Anna Wilde Mathews
The Centers for Medicare and Medicaid Services announced the increase for 2026 payment rates on Monday. Investors are expected to view the bump as a sign of the Trump administration’s support for Medicare Advantage, the program under which private insurers administer the benefits of the federal program for older and disabled Americans.
-
1 month ago |
wsj.com | Anna Wilde Mathews |Liz Essley Whyte
Biden administration had proposed late last year coverage of the popular medicines for obesityThe Trump administration said Friday that Medicare and Medicaid won’t expand coverage of popular anti-obesity drugs, rejecting a proposal issued late last year by the Biden administration. The decision deals a blow, at least for now, to Americans who are covered by the government health-insurance programs and wanted their help paying for the popular but pricey drugs.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 13K
- Tweets
- 1K
- DMs Open
- Yes
Privately run Medicare Advantage plans will get a sizable payment bump from the federal government, thanks to a 5.06% increase announced by the Trump administration Monday https://t.co/amlTadkmBi via @WSJ
Insurers collected $50 billion extra from Medicare by making questionable diagnoses, often without the knowledge of patients or their doctors. https://t.co/oYBB6LNaWu via @WSJ
Exclusive: Kaiser Permanente’s new Risant Health unit plans to acquire Cone Health, in a deal to build a network of nonprofit health systems across the U.S. https://t.co/lkBQH3wnxA via @WSJ